Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 52 of 52 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 11/30/13
Due: 11/30/14
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma | NCT05439993 | Hallym University Medical Center | user2@example.com | None | 2022-03-01 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |
| Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy | NCT01478516 | Hallym University Medical Center | user2@example.com | None | 2011-11-30 | 2013-11-30 | 2014-11-30 | - | - | 2025-07-14 |